Delegates attending this course will benefit from an introductory overview of the terminology and classification of cancer and the principle issues in its treatment. Commonly available anti-cancer drugs will be reviewed, including immunotherapies. The range of side-effects of cancer treatments will be studied in detail. Quality-of-life issues in terms of overall assessment and result interpretation will also be discussed.
Detailed consideration will be given to the treatment of major tumor types: breast, lung, upper gastrointestinal (GI), colorectal, melanoma, ovarian and prostate cancer. Each session will be presented by clinicians active in these areas and will focus on overall patient presentation and management and cancer diagnosis and staging. Following these sessions, our experts will lead delegates in interactive group discussions on the key issues relating to effective management of each tumor type.
The limitations of cytotoxic drugs currently available are well known. With this in mind, the course includes in-depth discussion on new drug development and identification of new pharmacological targets of particular interest and value. Clinical trial design issues will also be included.
Who Should Attend:
This course is developed specifically for the pharmaceutical, medical technology and biotechnology and associated healthcare industries. This oncology medical education program is ideal for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Jeffrey Crawford, M.D.
George Barth Geller Professor for Research in Cancer,
Department of Medicine Co-Director, Solid Tumor Therapeutics Program,
Duke Cancer Institute, Duke University Medical Center
Stephanie Gaillard, M.D.
Assistant Professor, Gynecologic Malignancies,
Division of Medical Oncology,
Duke Cancer Institute
Jeffrey Peppercorn, M.D.
Associate Professor Department of Medicine,
Harvard Medical School and Director, Survivorship Program
Massachusetts General Hospital
Bert O’Neil, M.D.
Professor of Medicine,
Director GI Oncology Program, Simon Cancer Center,
Indiana University School of Medicine, Indianapolis
Russell Schilder, M.D.
Professor of Medical Oncology, Obstetrics and Gynecology,
Chief, Gynecologic Medical Oncology,
Thomas Jefferson University
Stergios Moschos, M.D.
Clinical Associate Professor of Medicine,
University of North Carolina at Chapel Hill
Susan F. Slovin, M.D.
Member of Genitourinary Oncology Service,
Sidney Kimmel Center for Prostate & Urological Cancers,
Memorial Sloan-Kettering Cancer Center,
Professor of Medicine, Weill-Cornell Medical College
Who Should Attend: Healthcare’s courses are designed for both medical and non-medical staff within the pharmaceutical industry. This course is suitable for clinical research, medical information, regulatory affairs, biometrics and strategic marketing personnel.
Course Venue/Administrative Details: This course will be held at the Crowne Plaza Foster City. Full joining instructions will be emailed to delegates upon registration. Accommodation costs are not included in the registration fee.The registration fee at CHI’s VIP Discount Rate is $4,985 USD (regular rate $4,237 USD). You save 15% off your registration by registering through Cambridge Healthtech Institute (CHI). This includes lunch and refreshments throughout the day. Accommodation costs are not included. Delegates can register on-line or by completing the booking form and returning it together with the appropriate payment to Cambridge Healthtech Institute. Please retain a copy of the booking form for your records. * Please note: This course is organized by Healthcare Education Services and is being co-marketed by Cambridge Healthtech Institute (CHI). By registering through CHI, you save 15% off the registration rate charged by Healthcare Education Services. Please note: No refund/credit of registration fee will be made for any cancellations received less than 20 working days prior to the date of the course. Cancellations made more than 20 working days prior to course date will incur a $175 administration fee. Substitutions may be made at any time. If Healthcare cancels or postpones this event, the registration fee will be refunded. Healthcare will not accept liability for any other costs. Please read our Booking Conditions.
250 First Avenue, Suite 300
Needham, MA 02494
Biological Therapeutic Products
Biomarkers & Diagnostics
Bioprocess & Manufacturing
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
IT & Informatics
Technology & Tools For Life Science
Cambridge Healthtech Institute
Cambridge Innovation Institute